D351-0155 Screening compound: 5-{[(4-methoxyphenyl)amino]methyl}-2-(4-methylphenyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one

D351-0155 Screening compound: 5-{[(4-methoxyphenyl)amino]methyl}-2-(4-methylphenyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
D351-0155 Screening compound: 5-{[(4-methoxyphenyl)amino]methyl}-2-(4-methylphenyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound D351-0155
5-{[(4-methoxyphenyl)amino]methyl}-2-(4-methylphenyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D351-0155

Molecular Formula

C20H19N5O2 (C20 H19 N5 O2)

Compound Name

5-{[(4-methoxyphenyl)amino]methyl}-2-(4-methylphenyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one

IUPAC name

5-{[(4-methoxyphenyl)amino]methyl}-2-(4-methylphenyl)-4H7H-[124]triazolo[15-a]pyrimidin-7-one

SMILES

Cc(cc1)ccc1-c(nc1NC(CNc(cc2)ccc2OC)=C2)nn1C2=O

InChI

InChI=1S/C20H19N5O2/c1-13-3-5-14(6-4-13)19-23-20-22-16(11-18(26)25(20)24-19)12-21-15-7-9-17(27-2)10-8-15/h3-11,21H,12H2,1-2H3,(H,22,23,24)

InChI Key

LJTNQXFHCNXXLW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14822085

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

361.4

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.676

Distribution Coefficient, logD

3.472

Water Solubility, LogSw

-4.00

Polar Surface Area

69.119

Acid Dissociation Constant (pKa)

7.62

Base Dissociation Constant (pKb)

4.60

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.00

D351-0155 in Drug Discovery

Included in Screening Libraries

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with D351-0155 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D351-0155?
Check Price and Availability of D351-0155, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D351-0155 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D351-0155
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D351-0155
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D351-0155 available by request